Literature DB >> 26174536

RIPping the Skin Apart: Necroptosis Signaling in Toxic Epidermal Necrolysis.

Diana Panayotova-Dimitrova1, Maria Feoktistova1, Martin Leverkus2.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare but potentially fatal drug hypersensitivity reaction. Although a number of pathophysiological hints have been identified over the past decade, details of the effector mechanisms within the skin remain obscure. A novel study by Kim et al. now sheds light on its pathophysiology. The investigators demonstrate convincingly that receptor-interacting kinase 3 (RIPK3) levels are upregulated substantially in the lesional skin of patients with TEN and that this is followed by the generation of reactive oxygen species, activation of mixed lineage kinase-like protein, and subsequent necroptotic cell death of keratinocytes. These data suggest that therapies that interfere with RIPK3 activation and necroptosis induction could benefit patients with TEN.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26174536     DOI: 10.1038/jid.2015.159

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

1.  Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Jui-Yung Yang; Shih-Chi Su; Shien-Ping Huang; Chun-Yu Wei; See-Wen Chin; Chien-Chun Chiou; Sung-Chao Chu; Hsin-Chun Ho; Chih-Hsun Yang; Chi-Fang Lu; Jer-Yuarn Wu; You-Di Liao; Yuan-Tsong Chen
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

2.  cFLIP regulates skin homeostasis and protects against TNF-induced keratinocyte apoptosis.

Authors:  Diana Panayotova-Dimitrova; Maria Feoktistova; Michaela Ploesser; Beate Kellert; Mike Hupe; Sebastian Horn; Roman Makarov; Federico Jensen; Stefan Porubsky; Astrid Schmieder; Ana Claudia Zenclussen; Alexander Marx; Andreas Kerstan; Peter Geserick; You-Wen He; Martin Leverkus
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

3.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

Review 4.  Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.

Authors:  Wen-Hung Chung; Shuen-Iu Hung
Journal:  J Dermatol Sci       Date:  2012-04-11       Impact factor: 4.563

5.  Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis.

Authors:  P Paquet; A Nikkels; J E Arrese; A Vanderkelen; G E Piérard
Journal:  Arch Dermatol       Date:  1994-05

6.  An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions.

Authors:  Nao Saito; Hongjiang Qiao; Teruki Yanagi; Satoru Shinkuma; Keiko Nishimura; Asuka Suto; Yasuyuki Fujita; Shotaro Suzuki; Toshifumi Nomura; Hideki Nakamura; Koji Nagao; Chikashi Obuse; Hiroshi Shimizu; Riichiro Abe
Journal:  Sci Transl Med       Date:  2014-07-16       Impact factor: 17.956

7.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

8.  Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions.

Authors:  Asako Ichihara; Zhongzhi Wang; Masatoshi Jinnin; Yuki Izuno; Naoki Shimozono; Keitaro Yamane; Akihiko Fujisawa; Chikako Moriya; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  J Allergy Clin Immunol       Date:  2013-11-01       Impact factor: 10.793

9.  The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

Authors:  Tencho Tenev; Katiuscia Bianchi; Maurice Darding; Meike Broemer; Claudia Langlais; Fredrik Wallberg; Anna Zachariou; Juanita Lopez; Marion MacFarlane; Kelvin Cain; Pascal Meier
Journal:  Mol Cell       Date:  2011-07-07       Impact factor: 17.970

10.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

View more
  3 in total

Review 1.  Post-translational control of RIPK3 and MLKL mediated necroptotic cell death.

Authors:  James M Murphy; James E Vince
Journal:  F1000Res       Date:  2015-11-19

2.  Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma.

Authors:  Ahmed I Tahseen; Neel B Patel
Journal:  JAAD Case Rep       Date:  2018-10-10

3.  TNF Is Partially Required for Cell-Death-Triggered Skin Inflammation upon Acute Loss of cFLIP.

Authors:  Maria Feoktistova; Roman Makarov; Martin Leverkus; Amir S Yazdi; Diana Panayotova-Dimitrova
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.